CUMBERLAND PHARMACEUTICALS ACQUIRES SANCUSO® FROM KYOWA KIRIN NORTH AMERICA

Author's Avatar
Jan 04, 2022

Nashville-based pharmaceutical company will acquire U.S. rights from Japan-based Kyowa Kirin

SANCUSO® is an established, FDA-Approved Oncology Supportive Care Medicine

PR Newswire